Call for Papers  

Article Details


General Research Article

A Role for the Adenosine ADORA2B Receptor in Midazolam Induced Cognitive Dysfunction

[ Vol. 26 , Issue. 34 ]

Author(s):

Jennifer Gile, Yoshimasa Oyama, Sydney Shuff and Tobias Eckle*   Pages 4330 - 4337 ( 8 )

Abstract:


Background: We recently reported a role for the circadian rhythm protein Period 2 (PER2) in midazolam induced cognitive dysfunction. Based on previous studies showing a critical role for the adenosine A2B receptor (ADORA2B) in PER2 regulation, we hypothesized that hippocampal ADORA2B is crucial for cognitive function.

Methods: Midazolam treated C57BL/6J mice were analyzed for Adora2b hippocampal mRNA expression levels, and spontaneous T-maze alternation was determined in Adora2b-/- mice. Using the specific ADORA2B agonist BAY-60-6583 in midazolam treated C57BL/6J mice, we analyzed hippocampal Per2 mRNA expression levels and spontaneous T-maze alternation. Finally, Adora2b-/- mice were assessed for mRNA expression of markers for inflammation or cognitive function in the hippocampus.

Results: Midazolam treatment significantly downregulated Adora2b or Per2 mRNA in the hippocampus of C57BL/6J mice, and hippocampal PER2 protein expression or T-maze alternation was significantly reduced in Adora2b-/- mice. ADORA2B agonist BAY-60-6583 restored midazolam mediated reduction in spontaneous alternation in C57BL/6J mice. Analysis of hippocampal Tnf-α or Il-6 mRNA levels in Adora2b-/- mice did not reveal an inflammatory phenotype. However, C-fos, a critical component of hippocampus-dependent learning and memory, was significantly downregulated in the hippocampus of Adora2b-/- mice.

Conclusion: These results suggest a role of ADORA2B in midazolam induced cognitive dysfunction. Further, our data demonstrate that BAY-60-6583 treatment restores midazolam induced cognitive dysfunction, possibly via increases of Per2. Additional mechanistic studies hint towards C-FOS as another potential underlying mechanism of memory impairment in Adora2b-/- mice. These findings suggest the ADORA2B agonist as a potential therapy in patients with midazolam induced cognitive dysfunction.

Keywords:

Adora2b, cognitive function, Per2, T maze, C-fos, Bdnf, delirium, BAY-60-6583.

Affiliation:

Department of Anesthesiology, University of Colorado School of Medicine, Aurora, CO 80045, Department of Anesthesiology, University of Colorado School of Medicine, Aurora, CO 80045, Department of Anesthesiology, University of Colorado School of Medicine, Aurora, CO 80045, Department of Anesthesiology, University of Colorado School of Medicine, Aurora, CO 80045



Read Full-Text article